Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003597304 | SCV002335054 | benign | FG syndrome | 2023-11-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004631945 | SCV005133849 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2024-06-06 | criteria provided, single submitter | clinical testing | The c.2280G>A variant (also known as p.V760V), located in coding exon 16 of the MED12 gene, results from a G to A substitution at nucleotide position 2280. This nucleotide substitution does not change the amino acid at codon 760. This nucleotide position is well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration may result in the creation or strengthening of a novel splice acceptor site. Based on data from gnomAD, the A allele has an overall frequency of 0.001% (2/202742) total alleles studied, with 2 hemizygote(s) observed. The highest observed frequency was 0.0022% (2/91895) of European (non-Finnish) alleles. Based on the available evidence, the clinical significance of this variant remains unclear. |